When was Anamay Biotech founded?

Anamay Biotech was founded in 2017.

Where is Anamay Biotech located?

Anamay Biotech is headquartered in Hyderabad, India. It is registered at Ground floor, Plot No. 2 Padmaja Co-op Housing Society, Kakaguda, Karkhana, Hyderabad, Hyderabad, Telangana, India, 500015.

Who is the current CEO of Anamay Biotech?

Jalachari Ella of Anamay Biotech. They have also founded 1 company.

How many employees does Anamay Biotech have?

As of Jun 30, 2026, the latest employee count at Anamay Biotech is 28.

Is Anamay Biotech a funded company?

Anamay Biotech is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Anamay Biotech?

Annual revenue of Anamay Biotech is between ₹10 Cr and ₹50 Cr as on Mar 31, 2025

Where does Anamay Biotech rank among its competitors?

Anamay Biotech ranks 1047th amongst 2570 active competitors, of which 865 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Anamay Biotech?

Anamay Biotech's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Immuneel secured the most recent funding round in June, 2026.

Anamay Biotech - 2026 Company Profile, Team, Competitors & Financials

Anamay Biotech is an unfunded company based in Hyderabad (India), founded in 2017 by Jalachari Ella. It operates as a Developer of dermatology-related products, including therapeutics, cosmeceuticals, and baby care. Anamay Biotech has not raised any funding yet. The company has 2570 active competitors, including 865 funded and 628 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.

Company Details

Developer of dermatology-related products, including therapeutics, cosmeceuticals, and baby care. It offers Recombinant Growth Factors as products to address various skin-related concerns and offer innovative solutions for wound care and tissue repair.

Website: anamaybiotech.com
Social
Email ID: *****@anamaybiotech.com
Registered Address: Ground floor, Plot No. 2 Padmaja Co-op Housing Society, Kakaguda, Karkhana, Hyderabad, Hyderabad, Telangana, India, 500015

Key Metrics

Founded Year

2017

Location

Hyderabad, India

Stage

Unfunded

Ranked

1047^th among 2570 active competitors

Annual Revenue

₹10 - ₹50 Cr as on Mar 31, 2025

Employee Count

28 as on Jun 30, 2026

Similar Companies

LEO Pharma & 170 more

View Anamay Biotech's full profile

Anamay Biotech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ANAMAY BIOTECH PRIVATE LIMITED CIN: U73100TG2017PTC117308 , India, Active	May 24, 2017	₹10 - ₹50 Cr (As on Mar 31, 2025)	83 (As on Mar 31, 2024)

Anamay Biotech has not raised any funding rounds yet.

The founders of Anamay Biotech is Jalachari Ella. Jalachari Ella is the CEO of Anamay Biotech.

Here are the details of Anamay Biotech's key team members:

Jalachari Ella: Founder & CEO of Anamay Biotech.

View details of Anamay Biotech's Founder profiles and Board Members

Anamay Biotech's employee count trend

Anamay Biotech has 28 employees as of Jun 26. Here is Anamay Biotech's employee count trend over the years:

Uncover Anamay Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Anamay Biotech include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Anamay Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, F-Prime Capital & 17 others	73/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
4th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
5th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Domain Associates, Fidelity Investments & 19 others	72/100
6th	LEO Pharma 1908, Copenhagen (Denmark), Late Stage	Developer of drugs for treating dermatology diseases	$560M	Nordic Capital	71/100
7th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	71/100
8th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
9th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	71/100
10th	Elicio 2012, Cambridge (United States), Public	Developer of vaccines for treating cancer	$47.4M	Dreavent, Livzon Pharmaceutical & 5 others	71/100
1047th	Anamay Biotech 2017, Hyderabad (India), Unfunded	Developer of dermatology-related products, including therapeutics, cosmeceuticals, and baby care	-	-	36/100